WO2025109524 - ASSAYS AND METHODS FOR ASSESSING VACCINE PREPARATIONS
National phase entry is expected:
Publication Number
WO/2025/109524
Publication Date
30.05.2025
International Application No.
PCT/IB2024/061688
International Filing Date
21.11.2024
Title **
[English]
ASSAYS AND METHODS FOR ASSESSING VACCINE PREPARATIONS
[French]
DOSAGES ET PROCÉDÉS D'ÉVALUATION DE PRÉPARATIONS VACCINALES
Applicants **
AC IMMUNE SA
Inventors
FERTIN, Rémi
KOSCO-VILBOIS, Marie
NEVOLTRIS, Damien
Priority Data
63/601,866
22.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5057 | |
| EPO | Filing, Examination, Granting | 101237 | |
| Japan | Filing, Examination, Granting | 4876 | |
| South Korea | Filing, Examination, Granting | 7705 | |
| USA | Filing, Examination, Granting | 22340 |
Total:
141,215
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are assays and methods of assessing vaccine preparations, and engineered B cell receptors (BCR) and engineered B cell lines used in such assays and methods.[French]
L'invention concerne des dosages et des procédés d'évaluation de préparations vaccinales, et des récepteurs de lymphocytes B (BCR) modifiés et des lignées de lymphocytes B modifiées utilisées dans de tels dosages et procédés.